Infectech Inc (IFEC) announces that preliminary data and results of a study which confirms laboratory proof-of-concept measurements have shown it possible to generate hydrogen in high yields via the use and adaptation of its intellectual property. In this study, the bioreactor produced biogas consisting of 50% hydrogen by volume, without any trace of methane. Recently, NanoLogix, Inc. (formerly Infectech, Inc.) signed a feasibility study with the Department of Environmental Science and Engineering of Gannon University in Erie, PA to develop a bioreactor which utilizes NanoLogix’s patented bacterial culturing methods in order to produce hydrogen inexpensively. [ more ]
